Talk:Discovery and development of angiotensin receptor blockers

Merge?
A merge with the Angiotensin II receptor antagonist article may be a good idea. We don't need two separate articles. --PFHLai (talk) 15:39, 17 November 2008 (UTC)


 * This article was written as a part of a school project and we weren't allowed to base it on a page that already excisted. I actually think this one is much better than the Angiotensin II receptor antagonist article. But merge is not a bad idea.--Elinborgus


 * Yes, it's much, much better. :-) Please see WT:PHARM. --PFHLai (talk) 13:24, 18 November 2008 (UTC)

In my opinion it is not critical to merge. It is a very interestring story. By the way, there is a small mistake on the structure of eprosartan. There is no peroxyde group on that molecule. --Chemistlanglois 3:35, 20 november 2011